For comments, suggestions
Created with Raphaël 2.1.0 24.05.2017 Filing date 24.12.2018 Validation fee payment 31.05.2019 (A1) Patent application published 14.05.2024 AGEPI application filing date 31.08.2024 (T2) Translation of the validated European patent 26.04.2025 24.05.2025 Valid until 25.05.2026 Renewal fee to be paid until 24.05.2037 Patent will expire on

Patent in force


(210)Number of the EPO application17731337
(220)Filing date of the EPO application2017.05.24
(80)EPO patent specification publication (B)EPB nr. 13/2024, 2024.03.27
(110)EPO patent number3464306
(11)Number of the documentMD 3464306 T2
(21)Number of the applicatione 2019 0424
(71)Name(s) of applicant(s), code of the countrySAREPTA THERAPEUTICS, INC., US;
(72)Name(s) of inventor(s), code of the countryCAI Bao, US;
MARTINI Mitchell, US;
SHIMABUKU Ross, US;
THOMAS Katie, US;
(73)Name(s) of owner(s), code of the countrySAREPTA THERAPEUTICS, INC., US;
(54)Title of the inventionProcesses for preparing phosphorodiamidate morpholino oligomers
(13)Kind-of-document code T2
(51)International Patent Classification C07F 9/6558 (2006.01.01); C07F 9/6561 (2006.01.01); A61P 21/00 (2006.01.01)
(19)CountryUS
(41)Date of publication of the application2019.05.31
(49)Date of publication of the translation of the validated European patent specification2024.08.31
(30)Priority201662340953 P, 2016.05.24, US; 201662357134 P, 2016.06.30, US
(74)Patent attorney(Procedură) CORCODEL Angela, Bd. Ştefan cel Mare nr. 134, Chişinău, Republica Moldova
(86)International applicationPCT/US2017/034284, 2017.05.24
(87)International publicationWO 2017/205513, 2017.11.30
Up
/Inventions/details/3464306